跳至主要内容
临床试验/NCT05788848
NCT05788848已完成1 期

Virtual Reality Cognitive Therapy for Alzheimer's Disease

Claritytek, Inc.2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年3月31日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
36
试验地点
2
主要终点
Feasibility and Usability of Virtual Reality Cognitive Therapy (VRCT) for Alzheimer's Patients: Assessment of Patient-Reported Simulator Sickness and System Usability using The Simulator Sickness Questionnaire and System Usability Scale

研究概览

简要总结

To evaluate the usability, feasibility, and acceptability of VRCT iteratively on 36 AD/ADRD individuals with mild to moderate CI.

详细描述

Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD) resulting in cognitive decline affects more than 5.8 million Americans. Given the impact on quality of life, there is a great need for therapies focused on cognition. In this study, we will test the feasibility, usability, and acceptability of a novel Virtual Reality Cognitive Therapy (VRCT) for AD developed by ClarityTek, Inc. The VRCT will focus primarily on skills that impact instrumental activities of daily living (e.g., taking medications, shopping). Thirty-six individuals with mild to moderate AD/ADRD will be enrolled and will utilize the VRCT over seven weeks within their home. Enrollment will occur in cohorts of 12 individuals, so that the VRCT can be revised and optimized based on the results, prior to the next cohort. We will also hold Expert Focus Groups with clinician specialists to obtain feedback for improvement.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

盲法说明

This study is a phase I, feasibility study for research and development of a product. We will use a single group, pre-post study design. Individuals with mild to moderate CI (diagnosis of mild cognitive impairment (MCI), probable Alzheimer's disease (AD), or Alzheimer's disease Related Dementias (ADRD)

入排标准

年龄范围
30 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of mild cognitive impairment (MCI), probable Alzheimer's disease (AD) or Alzheimer's disease Related Dementias (ADRD)
  • Montreal Cognitive Assessment (MoCA) score of 11-25
  • Age 30-89

排除标准

  • Non-English speaking
  • History of seizure disorder, vertigo disorder, or severe motion sickness that would impact their ability to participate in the intervention
  • History of any other serious condition that may limit their ability to participate in the intervention, as determined by the investigators.
  • Inability to use the VR device (e.g., severe visual/hearing impairment, aphasia, facial injuries)

结局指标

主要结局

Feasibility and Usability of Virtual Reality Cognitive Therapy (VRCT) for Alzheimer's Patients: Assessment of Patient-Reported Simulator Sickness and System Usability using The Simulator Sickness Questionnaire and System Usability Scale

时间窗: from baseline at 7 weeks

Patient-Reported Simulator Sickness and System Usability using The Simulator Sickness Questionnaire and System Usability Scale Questionnaire

Acceptability of Virtual Reality Cognitive Training (VRCT) for Alzheimer's Patients: Assessment of Patient-Reported Acceptability using Free-Form Suggestion Feedback

时间窗: from baseline at 7 weeks

Patient-reported Acceptability of VRCT using Free-Form Suggestion Feedback such as acceptable, not acceptable or acceptable with changes.

次要结局

  • Instrumental Activities of Daily Living (IADL) performance(from baseline at 7 weeks)
  • Cognitive Impairment (CI)(from baseline at 7 weeks)
  • Anxiety and Depression(from baseline at 7 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验